Effectiveness of sequential treatment of advanced or metastatic renal cell carcinoma (mRCC). Outcome data from the clinical RCC Registry. 2. Juni 2013 Goebell, P.J., Müller, L., Lück, A., Overkamp, F., Vogt, M., Marschner, N., 2013. Onkologie 36 (suppl. 7)(V40), 8. doi:10.1159/000356365 Abstract The German mRCC Registry – aims and results after the first 1000 patients. Goebell, P.J., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Vogt, M., Marschner, N., 2013. Eur Urol Suppl 2013;12;e1106 DOI:10.1016/S1569-9056(13)61581-X… Weiterlesen Efficacy of trastuzumab re-therapy in routine treatment of HER2-positive breast cancer patients who relapsed after completed (neo-)adjuvant anti-HER2 therapy. Hanker, L., Hitschold, T., Hesse, T., Grafe, A., Förster, F., Schröder, J., Janssen, J., Reichert, D., Hielscher, C., Greinemann, J., Bórquez, D., Schmidt, M., 2013. Weiterlesen